Stockreport

Guardant Health: Look For Explosive Revenue Growth Ahead [Seeking Alpha]

Guardant Health, Inc.  (GH) 
Last guardant health, inc. earnings: 2/24 04:03 pm Check Earnings Report
PDF GH's Shield is the first FDA-approved blood test for primary colorectal cancer screening, with rapid early adoption and significant pricing power due to ADLT status. [Read more]